OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
Yi‐Yao Chang, Bo‐Ching Lee, Zheng‐Wei Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Yi‐Yao Chang, Bo‐Ching Lee, Zheng‐Wei Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Showing 8 citing articles:
Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
Michael Kitlinski, Karl Dreja, Zbigniew Heleniak, et al.
Kidney and Dialysis (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Michael Kitlinski, Karl Dreja, Zbigniew Heleniak, et al.
Kidney and Dialysis (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Comparison of the clinical significance of lymphocyte-based inflammatory indices between the two major subtypes of primary aldosteronism
Daisuke Watanabe, Satoshi Morimoto, Noriko Morishima, et al.
Endocrine (2025)
Closed Access
Daisuke Watanabe, Satoshi Morimoto, Noriko Morishima, et al.
Endocrine (2025)
Closed Access
Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis
Wen-Yu Ho, Ching-Chung Hsiao, Ping‐Hsun Wu, et al.
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 3
Wen-Yu Ho, Ching-Chung Hsiao, Ping‐Hsun Wu, et al.
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 3
Emerging association between KCNJ5 mutations and vascular failure in primary aldosteronism
Kota Jojima, Atsushi Tanaka, Koichi Node
Hypertension Research (2023) Vol. 46, Iss. 11, pp. 2547-2550
Open Access | Times Cited: 3
Kota Jojima, Atsushi Tanaka, Koichi Node
Hypertension Research (2023) Vol. 46, Iss. 11, pp. 2547-2550
Open Access | Times Cited: 3
The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
Sen Yang, Liyun Liu, Xiaoyun Liu, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e36046-e36046
Open Access | Times Cited: 2
Sen Yang, Liyun Liu, Xiaoyun Liu, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e36046-e36046
Open Access | Times Cited: 2
Conn’s syndrome - role as a secondary cause of arterial hypertension
Vitorino Modesto dos Santos, Lister Arruda Modesto dos Santos, Taciana Arruda Modesto Sugai
Brasília Médica (2024) Vol. 62
Open Access
Vitorino Modesto dos Santos, Lister Arruda Modesto dos Santos, Taciana Arruda Modesto Sugai
Brasília Médica (2024) Vol. 62
Open Access
Clinical value of 68Ga-pentixafor PET/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study
Rui Zuo, Shuang Liu, Wenbo Li, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access
Rui Zuo, Shuang Liu, Wenbo Li, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access
The relationship between tissue inhibitor of metalloproteinases-1 and KCNJ5 mutation in aldosterone-producing adenoma patients
Niang‐Cheng Lin, Tsung-Yan Chen, Xue‐Ming Wu, et al.
Hypertension Research (2024)
Closed Access
Niang‐Cheng Lin, Tsung-Yan Chen, Xue‐Ming Wu, et al.
Hypertension Research (2024)
Closed Access
